DANCANN PHARMA A/S
CVR 39426005 · Public limited company (A/S) · In bankruptcy
DANCANN PHARMA A/S is a Public limited company (A/S), founded on , based in Ansager. The company is registered in the industry fremstilling af farmaceutiske præparater. DANCANN PHARMA A/S went bankrupt on – 8.3 years after it was founded. 7 annual reports have been published. The latest annual report (31 Dec 2024) shows equity of DKK 14.6m and a net result of DKK -8.3m.
Bankruptcy
- Bankruptcy date
- Status
- In bankruptcy proceedings
- Age at bankruptcy
- 8.3 years
Company details
- CVR number
- 39426005
- Status
- In bankruptcy
- Company type
- Public limited company (A/S)
- Founded
- Address
- Rugvænget 5
6823 Ansager - Municipality
- Varde
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 4.0m
- Employees
- 1 (2018)
- Auditor
- Deloitte Statsautoriseret Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 7 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 91.5% |
| Current ratio | 190% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 7 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2024 | 2023 |
|---|---|---|
| Revenue | DKK 0 | DKK 0 |
| Gross profit | DKK -148k | DKK -5.3m |
| Net profit | DKK -8.3m | DKK -62.3m |
| Equity | DKK 14.6m | DKK 9.5m |
| Total assets | DKK 16.0m | DKK 17.7m |
| Cash | DKK 1.7m | – |
| Short-term debt | DKK 1.4m | – |
| Avg. employees | 5 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Deloitte Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2024 – 31 Dec 2024 | 136 | ||
| 1 Jan 2023 – 31 Dec 2023 | 166 | ||
| 1 Jan 2022 – 31 Dec 2022 | 166 | ||
| 1 Jan 2021 – 31 Dec 2021 | 125 | ||
| 1 Jan 2020 – 31 Dec 2020 | 127 | ||
| 1 Jan 2019 – 31 Dec 2019 | 64 | ||
| 20 Mar 2018 – 31 Dec 2018 | 99 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| Board | Carsten Trads | ||
| Board | Magnus Østergaard Dahlmann | ||
| Board | Per Wester | ||
| Board | Jeppe Krog Rasmussen | ||
| Board | Carsten Trads | ||
| Board | Magnus Østergaard Dahlmann | ||
| Board | Christian Carlsen | ||
| Board | Christian Carlsen | ||
| Board | Tue Østergaard | ||
| Board | Jeppe Krog Rasmussen | ||
| Board | Alexander Schoeneck | ||
| Board | Louise Bertelsen Forman | ||
| Board | Jes Lunde | ||
| Owner (5%) | JEQ Capital AB | Current | |
| Owner (100%) | Jeppe Krog Rasmussen | ||
| Owner (100%) | XIGNOTUS CAPITAL ApS | ||
| Owner (5%) | Morten Martinsen | ||
| Owner (20%) | Alexander Schoeneck | ||
| Owner (0%) | Nips Isolering ApS | ||
| Owner (67%) | XIGNOTUS CAPITAL ApS | ||
| Owner (0%) | HeRoed ApS | ||
| Owner (0%) | JBJensen ApS | ||
| Owner (0%) | VaVi Invest ApS | ||
| Owner (50%) | XIGNOTUS CAPITAL ApS | ||
| Owner (33%) | XIGNOTUS CAPITAL ApS | ||
| Owner (10%) | Alexander Schoeneck | ||
| Owner (5%) | Leif Andreas Johansson | ||
| Owner (5%) | Futur Pension Försäkringsaktiebolag | ||
| Owner (25%) | XIGNOTUS CAPITAL ApS | ||
| Owner (5%) | Alexander Schoeneck | ||
| Owner (20%) | XIGNOTUS CAPITAL ApS | ||
| Owner (5%) | JJV Invest AB | ||
| Owner (5%) | XIGNOTUS CAPITAL ApS | ||
| Owner (25%) | ABO Infinium Americas OpCo LTD. | ||
| Owner (10%) | JEQ Capital AB | ||
| Auditor | BDO Holding VII, statsautoriseret revisionsaktieselskab | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | Jeppe Krog Rasmussen | Current |
Address history (1 moves)
| Rugvænget 5, 6823 Ansager | |
| Engsøparken 127, 7200 Grindsted |
Former names
| DANCANN PHARMA A/S | – now |
| DANCANN PHARMA ApS | – |
| DANCANN PHARMA IVS | – |
| DANCANN IVS | – |
Employees per year
Other companies at the same address
- ANSAGER A/S Bankrupt
- ANSAGER FURNITURE & DOORS A/S Bankrupt
- BEST MARKETING GROUP A/S Bankrupt
- JP 6024370 AF 8. FEBRUAR 2007 A/S Bankrupt
- JP 6024823 AF 8. FEBRUAR 2007 A/S Bankrupt
- FAMILIEN FLUGT ApS Opløst
- OTC Group ApS Opløst
Questions and answers about DANCANN PHARMA A/S
Has DANCANN PHARMA A/S gone bankrupt?
Yes. DANCANN PHARMA A/S went bankrupt on 3 July 2026.
Who is the auditor of DANCANN PHARMA A/S?
DANCANN PHARMA A/S most recently used Deloitte Statsautoriseret Revisionspartnerselskab.
When was DANCANN PHARMA A/S founded?
DANCANN PHARMA A/S was founded on 20 March 2018.
What is the equity of DANCANN PHARMA A/S?
Equity was DKK 14.6m according to the annual report for the period ending 31 December 2024.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.